Smurfit Kappa Group Public Limited Company financials
Smurfit Kappa Group Public Limited Company
635400CPLP8H5ITDVT56 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | €11.27B | €12.81B |
| Cost of sales | €7.49B | €8.75B |
| Gross profit | €3.79B | €4.06B |
| Distribution costs | €927.0M | €961.0M |
| Administrative expenses | €1.46B | €1.44B |
| Operating profit (EBIT) | €1.25B | €1.44B |
| Finance costs | €257.0M | €184.0M |
| Profit before tax | €1.05B | €1.29B |
| Income tax expense | €296.0M | €348.0M |
| Profit for the year | €759.0M | €945.0M |
| — attributable to owners | €758.0M | €944.0M |
| — attributable to NCI | €1.0M | €1.0M |
| Total comprehensive income | €768.0M | €919.0M |
| Per share | ||
| Basic EPS | €2.94 | €3.65 |
| Diluted EPS | €2.91 | €3.62 |
| Cash flow statement | ||
| Cash generated from operations | €2.10B | €1.91B |
| Net cash from operating activities | €1.52B | €1.45B |
| Net cash from investing activities | -€831.0M | -€967.0M |
| Purchase of intangibles | €18.0M | €17.0M |
| Net cash from financing activities | -€550.0M | -€496.0M |
| Dividends paid | €367.0M | €333.0M |
| Lease liability payments | €106.0M | €103.0M |
| Net change in cash | €136.0M | -€11.0M |
| Balance sheet | ||
| Total assets | €12.63B | €12.48B |
| Non-current assets | €8.55B | €7.97B |
| Property, plant & equipment | €5.13B | €4.63B |
| Right-of-use assets | €353.0M | €345.0M |
| Intangible assets & goodwill | €2.67B | €2.67B |
| Current assets | €4.08B | €4.51B |
| Inventories | €1.02B | €1.23B |
| Trade & other receivables | €2.08B | €2.40B |
| Cash & equivalents | €905.0M | €788.0M |
| Total equity | €5.57B | €5.04B |
| — attributable to owners | €5.56B | €5.03B |
| Non-controlling interests | €14.0M | €13.0M |
| Non-current liabilities | €4.36B | €4.42B |
| Long-term borrowings | €3.57B | €3.60B |
| Current liabilities | €2.69B | €3.03B |
| Short-term borrowings | €175.0M | €180.0M |
| Trade & other payables | €2.38B | €2.64B |
| Deferred tax liabilities | €171.0M | €190.0M |
| Derived metrics | ||
| Operating margin | 11.1% | 11.2% |
| Net margin | 6.7% | 7.4% |
| Return on equity | 13.6% | 18.8% |
| Cash conversion ratio | 2.00× | 1.54× |
| Other reported items | ||
| Adjustments For Decrease Increase In Biological Assets | -€19.0M | -€2.0M |
| Adjustments For Depreciation Expense | €587.0M | €581.0M |
| Adjustments For Finance Costs | €198.0M | €149.0M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €12.0M | €7.0M |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | €0 | €85.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€43.0M | -€19.0M |
| Adjustments For Sharebased Payments | €61.0M | €65.0M |
| Adjustments For Undistributed Profits of Associates | €2.0M | €3.0M |
| Cancellation of Treasury Shares | — | €0 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €890.0M | €771.0M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€46.0M | €8.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €26.0M | €90.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.0M | €1.0M |
| Comprehensive Income Attributable To Owners of Parent | €767.0M | €918.0M |
| Consideration Paid Received | €4.0M | €14.0M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €4.08B | €4.47B |
| Current Biological Assets | €13.0M | €10.0M |
| Current Derivative Financial Assets | €17.0M | €46.0M |
| Current Derivative Financial Liabilities | €17.0M | €21.0M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €2.69B | €2.99B |
| Current Provisions | €124.0M | €100.0M |
| Current Tax Assets Current | €39.0M | €0 |
| Current Tax Assets Noncurrent | €12.0M | €0 |
| Current Tax Liabilities Current | €0 | €49.0M |
| Current Tax Liabilities Noncurrent | €0 | €16.0M |
| Deferred Tax Assets | €138.0M | €141.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €367.0M | €332.0M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €0 | €1.0M |
| Dividends Received Classified As Investing Activities | €1.0M | €1.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€17.0M | -€59.0M |
| Equity and Liabilities | €12.63B | €12.48B |
| Finance Income | €59.0M | €35.0M |
| Gains Losses On Cash Flow Hedges Net of Tax | -€1.0M | -€5.0M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €12.0M | -€63.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€11.0M | €8.0M |
| Increase Decrease In Working Capital | -€167.0M | €350.0M |
| Increase Decrease Through Sharebased Payment Transactions | €59.0M | €63.0M |
| Interest Paid Classified As Operating Activities | €178.0M | €135.0M |
| Interest Received Classified As Investing Activities | €28.0M | €9.0M |
| Investments In Associates Accounted For Using Equity Method | €19.0M | €16.0M |
| Issued Capital | €0 | €0 |
| Liabilities | €7.05B | €7.44B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €35.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €35.0M |
| Noncurrent Biological Assets | €156.0M | €100.0M |
| Noncurrent Derivative Financial Assets | €0 | €2.0M |
| Noncurrent Derivative Financial Liabilities | €1.0M | €4.0M |
| Noncurrent Government Grants | €34.0M | €26.0M |
| Noncurrent Provisions | €41.0M | €37.0M |
| Noncurrent Recognised Assets Defined Benefit Plan | €21.0M | €17.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €532.0M | €534.0M |
| Other Adjustments To Reconcile Profit Loss | €3.0M | €8.0M |
| Other Comprehensive Income | €9.0M | -€26.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€46.0M | €51.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €4.0M | -€5.0M |
| Other Comprehensive Income Net of Tax Change In Value of Foreign Currency Basis Spreads | — | -€1.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €40.0M | -€63.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€35.0M | €43.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €44.0M | -€69.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€35.0M | €43.0M |
| Other Expense By Function | €152.0M | €223.0M |
| Other Noncurrent Financial Assets | €10.0M | €10.0M |
| Other Noncurrent Payables | €11.0M | €10.0M |
| Other Noncurrent Receivables | €39.0M | €39.0M |
| Other Reserves | €311.0M | €236.0M |
| Proceeds From Government Grants Classified As Investing Activities | €13.0M | €6.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €16.0M | €12.0M |
| Purchase of Financial Instruments Classified As Investing Activities | €0 | €1.0M |
| Purchase of Treasury Shares | — | €41.0M |
| Reclassification Adjustments On Cash Flow Hedges Net of Tax | -€5.0M | €0 |
| Reclassification Adjustments On Change In Value of Foreign Currency Basis Spreads Net of Tax | €0 | €1.0M |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | -€28.0M | €0 |
| Retained Earnings | €2.60B | €2.14B |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €2.0M | €3.0M |
| Share Premium | €2.65B | €2.65B |
Every line item above is a fact tagged in Smurfit Kappa Group Public Limited Company's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.